e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Biomarkers and other new methods for lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Role of systemic and bronchial oxidative stress and inflammation in lung cancer predisposition in patients with COPD
C. Fermoselle, V. Curull, A. Sanchez-Font, L. Pijuan, J. Gea, E. Barreiro (Barcelona, Spain)
Source:
Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Session:
Biomarkers and other new methods for lung cancer
Session type:
Thematic Poster Session
Number:
2786
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Fermoselle, V. Curull, A. Sanchez-Font, L. Pijuan, J. Gea, E. Barreiro (Barcelona, Spain). Role of systemic and bronchial oxidative stress and inflammation in lung cancer predisposition in patients with COPD. Eur Respir J 2011; 38: Suppl. 55, 2786
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Role of systemic and muscle oxidative stress and cytokines in patients with lung cancer cachexia
Source: Annual Congress 2011 - Physiological basis of respiratory disease
Year: 2011
Increasing oxidative stress and inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD) and their association with lung function
Source: Annual Congress 2012 - The smoking gun in COPD biology
Year: 2012
Cachexia in patients with acute COPD exacerbations: relationship to pulmonary function, systemic inflammation and oxidative stress
Source: Annual Congress 2008 - Comorbidities in COPD
Year: 2008
The role of inflammation in COPD
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006
Comparison of the neutrophils oxidative activity in patients with occupational lung diseases and COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 119s
Year: 2003
Oxidative stress as common mechanism of inflammation in chronic lung diseases
Source: Eur Respir J 2005; 26: Suppl. 49, 344s
Year: 2005
Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007
Oxidative stress and airway inflammation in healthy smokers and COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 95s
Year: 2002
Mechanisms of development oxidative stress and progression chronic respiratory failure in patients with COPD
Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Year: 2009
Association of oxidative stress and inflammation with cardiovascular injury in chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis
Year: 2009
Sirt3-MnSOD signaling pathway attenuates airway epithelial mitochondrial oxidative stress in chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases
Year: 2020
Systemic inflammation and systemic oxidative stress in acute COPD exacerbation
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Relationship between oxidative stress, endothelial injury and coagulation activation in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Year: 2007
Neutrophils oxidative activity of patients with occupational lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 445s
Year: 2001
Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation
Source: Eur Respir J 2004; 24: Suppl. 48, 45s
Year: 2004
ER stress in chronic lung disease
Source: ERS Lung Science Conference 2017
Year: 2017
Inflammation biomarkers of lung tissue damage in acute exacerbation of COPD patients
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Oxidative stress and redox regulation of lung inflammation in COPD
Source: Eur Respir J 2006; 28: 219-242
Year: 2006
Dynamic hyperinflation contributes to systemic and airway inflammation in patients with COPD
Source: International Congress 2019 – Physiologic assessment of airway diseases
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept